Debarshi Dey

485 total citations
20 papers, 307 citations indexed

About

Debarshi Dey is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Epidemiology. According to data from OpenAlex, Debarshi Dey has authored 20 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Debarshi Dey's work include Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Debarshi Dey is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Debarshi Dey collaborates with scholars based in United States, Italy and France. Debarshi Dey's co-authors include B Steen, Ingvar Bosæus, Lauren Lissner, Elisabet Rothenberg, Valter Sundh, Cecilia Björkelund, Gabriele Eiben, Calle Bengtsson, Roberto Buzzoni and Éric Baudin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Debarshi Dey

18 papers receiving 296 citations

Peers

Debarshi Dey
Maxwell T. Vergo United States
Paweł Macek Poland
Hye Yeon Koo South Korea
P. Blanc France
Roberta Ortiz United States
Roma Bhatia United States
Kerrin Bleicher Australia
Shannon Cartier United States
Clara Fitzgerald United States
Chan Mi Park South Korea
Maxwell T. Vergo United States
Debarshi Dey
Citations per year, relative to Debarshi Dey Debarshi Dey (= 1×) peers Maxwell T. Vergo

Countries citing papers authored by Debarshi Dey

Since Specialization
Citations

This map shows the geographic impact of Debarshi Dey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debarshi Dey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debarshi Dey more than expected).

Fields of papers citing papers by Debarshi Dey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debarshi Dey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debarshi Dey. The network helps show where Debarshi Dey may publish in the future.

Co-authorship network of co-authors of Debarshi Dey

This figure shows the co-authorship network connecting the top 25 collaborators of Debarshi Dey. A scholar is included among the top collaborators of Debarshi Dey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debarshi Dey. Debarshi Dey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hossain, Sorif, et al.. (2025). Smoking among females in Bangladesh: A systematic review and meta-analysis. 5. 100180–100180.
2.
Dey, Debarshi, et al.. (2024). Suicide attempts in Bangladesh: Prevalence, trends, and disparities. 5. 100170–100170. 1 indexed citations
3.
Dey, Debarshi, et al.. (2024). The Impact of Socioeconomic Inequalities on the Risk of Hypertension in Bangladesh: A Systematic Review and Meta‐Analysis. Journal of Clinical Hypertension. 27(1). e14957–e14957. 2 indexed citations
4.
Gupta, Vikas, John Mascarenhas, Marina Kremyanskaya, et al.. (2023). Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis. Blood Advances. 7(18). 5421–5432. 4 indexed citations
5.
Mesa, Ruben A., Vikas Gupta, John Mascarenhas, et al.. (2023). Assessment of Minimal Clinically Important Difference in Patient-Reported Myelofibrosis-Associated Symptoms Using an Anchor-Based Analysis Based on MANIFEST Arm 3 Data. Blood. 142(Supplement 1). 3195–3195. 1 indexed citations
6.
Nowakowski, Grzegorz S., Matthew J. Maurer, James R. Cerhan, Debarshi Dey, & Laurie H. Sehn. (2022). Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma. American Journal of Hematology. 98(1). 180–192. 4 indexed citations
7.
Gupta, Vikas, John Mascarenhas, Marina Kremyanskaya, et al.. (2022). MPN-379 Matching-Adjusted Indirect Comparison (MAIC) of Pelabresib (CPI-0610) in Combination With Ruxolitinib vs. JAK Inhibitor Monotherapy in Patients With Intermediate or High-Risk Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia. 22. S336–S336. 2 indexed citations
8.
9.
10.
Siddabattuni, Sasidhar, et al.. (2021). Task-sharing to screen perinatal depression in resource limited setting in India: Comparison of outcomes based on screening by non-expert and expert rater. Asian Journal of Psychiatry. 62. 102738–102738. 6 indexed citations
11.
Siddabattuni, Sasidhar, et al.. (2020). Identification of clinical and psychosocial characteristics associated with perinatal depression in the south Indian population. General Hospital Psychiatry. 66. 161–170. 14 indexed citations
12.
Fazio, Nicola, Roberto Buzzoni, Éric Baudin, et al.. (2016). A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours.. PubMed. 36(2). 713–9. 73 indexed citations
13.
Soulières, Denis, Sandrine Faivre, Ricard Mesı́a, et al.. (2016). BERIL-1: A phase II, placebo-controlled study of buparlisib (BKM120) plus paclitaxel in patients with platinum-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 34(15_suppl). 6008–6008. 11 indexed citations
14.
Salazar, Ramón, Chris Verslype, Éric Baudin, et al.. (2015). Phase II studies of BEZ235 in patients with advanced pancreatic neuroendocrine tumors (pNET).. Journal of Clinical Oncology. 33(15_suppl). 4102–4102. 10 indexed citations
15.
Fazio, Nicola, Roberto Buzzoni, Éric Baudin, et al.. (2014). Ph Ii Study of Bez235 in Patients with Advanced Pancreatic Neuroendocrine Tumors (Pnet) After Mtor Inhibitor Therapy Failure: Stage I Interim Results. Annals of Oncology. 25. iv399–iv399. 4 indexed citations
16.
17.
Gause‐Nilsson, Ingrid, et al.. (2006). Prevalence of metabolic syndrome in an elderly Swedish population. Acta Diabetologica. 43(4). 120–126. 20 indexed citations
18.
Eiben, Gabriele, Debarshi Dey, Elisabet Rothenberg, et al.. (2005). Obesity in 70-year-old Swedes: Secular changes over 30 years. International Journal of Obesity. 29(7). 810–817. 51 indexed citations
19.
Dey, Debarshi, Ingvar Bosæus, Lauren Lissner, & B Steen. (2003). Body composition estimated by bioelectrical impedance in the Swedish elderly. Development of population-based prediction equation and reference values of fat-free mass and body fat for 70- and 75-y olds. European Journal of Clinical Nutrition. 57(8). 909–916. 54 indexed citations
20.
Dey, Debarshi, Elisabet Rothenberg, Valter Sundh, Ingvar Bosæus, & B Steen. (2001). Height and Body Weight in Elderly Adults: A 21-Year Population Study on Secular Trends and Related Factors in 70-Year-Olds. The Journals of Gerontology Series A. 56(12). M780–M784. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maxwell T. Vergo Breakdown of academic impact, for papers by Paweł Macek Breakdown of academic impact, for papers by Hye Yeon Koo Breakdown of academic impact, for papers by P. Blanc Breakdown of academic impact, for papers by Roberta Ortiz Breakdown of academic impact, for papers by Roma Bhatia Breakdown of academic impact, for papers by Kerrin Bleicher Breakdown of academic impact, for papers by Shannon Cartier Breakdown of academic impact, for papers by Clara Fitzgerald Breakdown of academic impact, for papers by Chan Mi Park
Rankless by CCL
2026